GlassScriptPhysician profile
Kathryn Miley
NPI 1154568764
$11,088.20
in general payments reported to CMS, 2019-2025
16 companies · $525 in 2025
The $525 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,721 · 2022: $2,174 · 2023: $4,189 · 2024: $2,480 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,143 · Food and Beverage: $2,883 · Consulting Fee: $936 · Travel and Lodging: $121 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,143.13 |
| Food and Beverage | $2,882.65 |
| Consulting Fee | $936.25 |
| Travel and Lodging | $120.73 |
| Education | $110.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $4,542.24 | 2021-2024 | Glassia |
| Astrazeneca Pharmaceuticals LP | $2,705.34 | 2021-2025 | Fasenra, Breztri, Tezspire |
| Glaxosmithkline, LLC. | $1,225.10 | 2021-2023 | Nucala, Trelegy Ellipta, Arexvy |
| Grifols Shared Services North America, INC. | $764.12 | 2021-2025 | Prolastin-C Liquid |
| Grifols USA, LLC | $448.09 | 2021-2023 | Prolastin-C Liquid |
| Mallinckrodt Hospital Products INC. | $402.61 | 2021-2023 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $316.35 | 2021-2023 | Stiolto Respimat, Ofev |
| Mylan Specialty L.P. | $197.41 | 2021-2023 | Yupelri |
| Regeneron Healthcare Solutions, INC. | $148.43 | 2021-2023 | Dupixent |
| Genzyme Corporation | $113.44 | 2021-2023 | |
| Advanced Respiratory, INC | $87.66 | 2021 | |
| Electromed, INC. | $53.51 | 2022-2023 | Smartvest |
| Philips North America LLC | $27.07 | 2021-2023 | |
| Pfizer INC. | $25.63 | 2023 | |
| Novartis Pharmaceuticals Corporation | $17.65 | 2023 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $13.55 | 2023 | Hillrom - Vest System Model 105 Home Care |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathryn Miley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.